Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Penetration of 1% voriconazole eye drops into human vitreous humour: a prospective, open-label study

Lau D, Leung L, Ferdinands M, Allen PJ, Fullinfaw RO, Davies GE, Kong DC

(2009), Clin Exp Ophthalmol, 37(2), 197-200

Oncology pharmacy preparatory review course

Larizza M

(2009), J Pharm Pract Res , 39(4), 333-4

Individualised foreign language medication lists for non-English speaking hospital patients

Larizza MA, Wilson R, Dooley MJ

(2009), J Pharm Pract Res , 39(4), 277-80

Assessing medication knowledge of Australian palliative cancer care patients and caregivers and their interactions with pharmacists

Hussainy SY, Marriott JL, Nation RL

(2009), Palliat Med, 12(9), 769

The management of prolonged, isolated hyperbilirubinemia following cytarabine-based chemotherapy for acute myeloid leukaemia

Coutsouvelis J, Corallo CE

(2009), J Oncol Pharm Pract, 15(2), 107-10

Anticholinergic syndrome following an unintentional overdose of scopolamine

Corallo CE, Whitfield A, Wu A

(2009), Ther Clin Risk Manag, 5(5), 719-23

Cost-effectiveness evaluation of voriconazole versus liposomal amphotericin B as empirical therapy for febrile neutropenia in Australia

Al-Badriyeh D, Liew D, Stewart K, Kong DC

(2009), J Antimicrob Chemother, 63(1), 197-208

Economic impact of caspofungin as compared with liposomal amphotericin B for empirical therapy in febrile neutropenia in Australia

Al-Badriyeh D, Liew D, Stewart K, Kong DC

(2009), J Antimicrob Chemother, 63(6), 1276-85

Intravenous olanzapine--another option for the acutely agitated patient?

Chan EW, Knott JC, Taylor DM, Phillips GA, Kong DC

(2009), Emerg Med Australas, 21(3), 241-2

Successful salvage treatment of Scedosporium apiospermum keratitis with topical voriconazole after failure of natamycin

Al-Badriyeh D, Leung L, Davies GE, Stewart K, Kong D

(2009), Ann Pharmacother, 43(6), 1139-42

Stability of extemporaneously prepared voriconazole ophthalmic solution

Al-Badriyeh D, Li J, Stewart K, Kong DC, Leung L, Davies GE, Fullinfaw R

(2009), Am J Health Syst Pharm, 66(16), 1478-83

Prospective open-label study of the administration of two-percent voriconazole eye drops

Al-Badriyeh D, Leung L, Roydhouse T, Fullinfaw R, Daniell M, Davies GE, Stewart K, Kong DC

(2009), Antimicrob Agents Chemother, 53(7), 3153-5

Successful use of topical voriconazole 1% alone as first-line antifungal therapy against Candida albicans keratitis

Al-Badriyeh D, Leung L, Davies GE, Stewart K, Kong D

(2009), Ann Pharmacother, 43(12), 2103-7

11C-PiB PET studies in typical sporadic Creutzfeldt-Jakob disease

Villemagne VL, McLean CA, Reardon K, Boyd A, Lewis V, Klug G, Jones G, Baxendale D, Masters CL, Rowe CC, Collins SJ

(2009), J Neurol Neurosurg Psychiatry, 80(9), 998-1001

Abnormal hippocampal distribution of TDP-43 in patients with-late onset psychosis

Velakoulis D, Walterfang M, Mocellin R, Pantelis C, Dean B, McLean C

(2009), Aust N Z J Psychiatry, 43(8), 739-45

Frontotemporal dementia presenting as schizophrenia-like psychosis in young people: clinicopathological series and review of cases

Velakoulis D, Walterfang M, Mocellin R, Pantelis C, McLean C

(2009), Br J Psychiatry, 194(4), 298-305

Cell-specific temporal infection of the brain in a simian immunodeficiency virus model of human immunodeficiency virus encephalitis

Thompson KA, Varrone JJ, Jankovic-Karasoulos T, Wesselingh SL, McLean CA

(2009), J Neurovirol , 15(4), 300-11

Disease status at autologous stem cell transplantation and the cell of origin phenotype are important predictors of outcome in patients with neurologic (central nervous system) relapse of diffuse large B-cell lymphoma undergoing autologous stem cell......

Patil S, Spencer A, Schwarer A, Avery S, Ritchie D, Opat S, Wei A, McLean C

(2009), Leuk Lymphoma, 50(12), 1964-8

pH measurement as quality control on human post mortem brain tissue: a study of the BrainNet Europe consortium

Monoranu CM, Apfelbacher M, Grünblatt E, Puppe B, Alafuzoff I, Ferrer I, Al-Saraj S, Keyvani K, Schmitt A, Falkai P, Schittenhelm J, Halliday G, Kril J, Harper C, McLean C, Riederer P, Roggendorf W

(2009), Neuropathol Appl Neurobiol, 35(3), 329-37

Tryptophan is a marker of human postmortem brain tissue quality

Grünblatt E, Monoranu CM, Apfelbacher M, Keller D, Michel TM, Alafuzoff I, Ferrer I, Al-Saraj S, Keyvani K, Schmitt A, Falkai P, Schittenhelm J, McLean C, Halliday GM, Harper C, Deckert J, Roggendorf W, Riederer P

(2009), J Neurochem, 110(5), 1400-8

680 681 682 683 684